annual FCF:
$17.83B-$4.23B(-19.17%)Summary
- As of today (April 16, 2025), ABBV annual free cash flow is $17.83 billion, with the most recent change of -$4.23 billion (-19.17%) on December 1, 2024.
- During the last 3 years, ABBV annual FCF has fallen by -$4.16 billion (-18.91%).
- ABBV annual FCF is now -26.46% below its all-time high of $24.25 billion, reached on December 31, 2022.
Performance
ABBV Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$6.76B+$1.56B(+29.99%)Summary
- As of today (April 16, 2025), ABBV quarterly free cash flow is $6.76 billion, with the most recent change of +$1.56 billion (+29.99%) on December 1, 2024.
- Over the past year, ABBV quarterly FCF has stayed the same.
- ABBV quarterly FCF is now -12.45% below its all-time high of $7.72 billion, reached on September 30, 2021.
Performance
ABBV quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$17.83B+$2.21B(+14.14%)Summary
- As of today (April 16, 2025), ABBV TTM free cash flow is $17.83 billion, with the most recent change of +$2.21 billion (+14.14%) on December 1, 2024.
- Over the past year, ABBV TTM FCF has stayed the same.
- ABBV TTM FCF is now -28.09% below its all-time high of $24.80 billion, reached on June 30, 2023.
Performance
ABBV TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
ABBV Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.2% | 0.0% | 0.0% |
| 3 y3 years | -18.9% | +39.0% | -19.7% |
| 5 y5 years | +39.6% | +117.1% | +6.2% |
ABBV Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -26.5% | at low | -9.0% | +232.9% | -28.1% | +14.1% |
| 5 y | 5-year | -26.5% | +39.6% | -12.4% | +232.9% | -28.1% | +31.6% |
| alltime | all time | -26.5% | +507.1% | -12.4% | +1024.3% | -28.1% | +1405.0% |
AbbVie Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $17.83B(-19.2%) | $6.76B(+30.0%) | $17.83B(+14.1%) |
| Sep 2024 | - | $5.20B(+156.1%) | $15.62B(-12.1%) |
| Jun 2024 | - | $2.03B(-47.2%) | $17.78B(-18.8%) |
| Mar 2024 | - | $3.85B(-15.4%) | $21.89B(-0.8%) |
| Dec 2023 | $22.06B(-9.0%) | $4.55B(-38.2%) | $22.06B(-10.8%) |
| Sep 2023 | - | $7.36B(+19.8%) | $24.73B(-0.3%) |
| Jun 2023 | - | $6.14B(+52.8%) | $24.80B(+5.4%) |
| Mar 2023 | - | $4.02B(-44.3%) | $23.52B(-3.0%) |
| Dec 2022 | $24.25B(+10.3%) | $7.21B(-2.8%) | $24.25B(+10.6%) |
| Sep 2022 | - | $7.42B(+52.7%) | $21.92B(-1.3%) |
| Jun 2022 | - | $4.86B(+2.4%) | $22.21B(+0.8%) |
| Mar 2022 | - | $4.75B(-2.9%) | $22.05B(+0.3%) |
| Dec 2021 | $21.99B(+31.0%) | $4.89B(-36.7%) | $21.99B(+1.4%) |
| Sep 2021 | - | $7.72B(+64.4%) | $21.68B(+10.8%) |
| Jun 2021 | - | $4.70B(+0.1%) | $19.57B(+10.0%) |
| Mar 2021 | - | $4.69B(+2.5%) | $17.79B(+5.9%) |
| Dec 2020 | $16.79B(+31.5%) | $4.58B(-18.5%) | $16.79B(+9.5%) |
| Sep 2020 | - | $5.61B(+92.8%) | $15.33B(+8.6%) |
| Jun 2020 | - | $2.91B(-21.1%) | $14.12B(+4.2%) |
| Mar 2020 | - | $3.69B(+18.6%) | $13.55B(+6.1%) |
| Dec 2019 | $12.77B(-0.1%) | $3.11B(-29.3%) | $12.77B(-1.2%) |
| Sep 2019 | - | $4.40B(+87.4%) | $12.93B(+1.2%) |
| Jun 2019 | - | $2.35B(-19.3%) | $12.77B(-3.1%) |
| Mar 2019 | - | $2.91B(-11.0%) | $13.17B(+3.0%) |
| Dec 2018 | $12.79B(+35.6%) | $3.27B(-22.9%) | $12.79B(+7.3%) |
| Sep 2018 | - | $4.24B(+54.1%) | $11.92B(+10.1%) |
| Jun 2018 | - | $2.75B(+8.9%) | $10.82B(+8.8%) |
| Mar 2018 | - | $2.53B(+5.2%) | $9.95B(+5.5%) |
| Dec 2017 | $9.43B | $2.40B(-23.6%) | $9.43B(+11.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $3.15B(+67.6%) | $8.46B(+27.1%) |
| Jun 2017 | - | $1.88B(-6.5%) | $6.65B(+1.4%) |
| Mar 2017 | - | $2.01B(+40.6%) | $6.56B(0.0%) |
| Dec 2016 | $6.56B(-6.3%) | $1.43B(+6.4%) | $6.56B(-5.6%) |
| Sep 2016 | - | $1.34B(-25.0%) | $6.95B(-9.0%) |
| Jun 2016 | - | $1.79B(-11.0%) | $7.64B(+0.9%) |
| Mar 2016 | - | $2.01B(+10.4%) | $7.57B(+8.1%) |
| Dec 2015 | $7.00B(+138.4%) | $1.82B(-10.4%) | $7.00B(+57.2%) |
| Sep 2015 | - | $2.03B(+18.1%) | $4.45B(+10.5%) |
| Jun 2015 | - | $1.72B(+19.2%) | $4.03B(+3.7%) |
| Mar 2015 | - | $1.44B(-297.0%) | $3.89B(+32.4%) |
| Dec 2014 | $2.94B(-49.2%) | -$731.00M(-145.5%) | $2.94B(-38.3%) |
| Sep 2014 | - | $1.61B(+2.0%) | $4.76B(-1.2%) |
| Jun 2014 | - | $1.57B(+223.4%) | $4.82B(-6.6%) |
| Mar 2014 | - | $487.00M(-55.5%) | $5.16B(-10.6%) |
| Dec 2013 | $5.78B(-3.9%) | $1.09B(-34.3%) | $5.78B(+4.5%) |
| Sep 2013 | - | $1.67B(-13.2%) | $5.53B(-9.8%) |
| Jun 2013 | - | $1.92B(+74.5%) | $6.13B(+7.9%) |
| Mar 2013 | - | $1.10B(+29.9%) | $5.68B(-5.5%) |
| Dec 2012 | $6.01B(+2.1%) | $846.00M(-62.7%) | $6.01B(-1.6%) |
| Sep 2012 | - | $2.27B(+54.5%) | $6.11B(+10.1%) |
| Jun 2012 | - | $1.47B(+2.4%) | $5.55B(-9.6%) |
| Mar 2012 | - | $1.43B(+51.7%) | $6.14B(+4.2%) |
| Dec 2011 | $5.89B(+30.1%) | $943.91M(-44.7%) | $5.89B(+19.1%) |
| Sep 2011 | - | $1.71B(-17.0%) | $4.95B(+52.6%) |
| Jun 2011 | - | $2.06B(+73.5%) | $3.24B(+173.5%) |
| Mar 2011 | - | $1.18B | $1.18B |
| Dec 2010 | $4.53B(-10.4%) | - | - |
| Dec 2009 | $5.05B | - | - |
FAQ
- What is AbbVie annual free cash flow?
- What is the all time high annual FCF for AbbVie?
- What is AbbVie annual FCF year-on-year change?
- What is AbbVie quarterly free cash flow?
- What is the all time high quarterly FCF for AbbVie?
- What is AbbVie quarterly FCF year-on-year change?
- What is AbbVie TTM free cash flow?
- What is the all time high TTM FCF for AbbVie?
- What is AbbVie TTM FCF year-on-year change?
What is AbbVie annual free cash flow?
The current annual FCF of ABBV is $17.83B
What is the all time high annual FCF for AbbVie?
AbbVie all-time high annual free cash flow is $24.25B
What is AbbVie annual FCF year-on-year change?
Over the past year, ABBV annual free cash flow has changed by -$4.23B (-19.17%)
What is AbbVie quarterly free cash flow?
The current quarterly FCF of ABBV is $6.76B
What is the all time high quarterly FCF for AbbVie?
AbbVie all-time high quarterly free cash flow is $7.72B
What is AbbVie quarterly FCF year-on-year change?
Over the past year, ABBV quarterly free cash flow has changed by $0.00 (0.00%)
What is AbbVie TTM free cash flow?
The current TTM FCF of ABBV is $17.83B
What is the all time high TTM FCF for AbbVie?
AbbVie all-time high TTM free cash flow is $24.80B
What is AbbVie TTM FCF year-on-year change?
Over the past year, ABBV TTM free cash flow has changed by $0.00 (0.00%)